06.01.04
Irvine, CA-based Next Pharmaceuticals’ patented proprietary botanical ingredient Relora® has been shown in a double-blind placebo-controlled clinical trial to help overweight, stressed individuals maintain or lower their weight. The trial was conducted by an independent clinical research organization, Miami Research Associates, under the direction of Diane Krieger, MD. The 40 subjects in this pilot trial were healthy, overweight, premenopausal women (BMI 25 to 34.9) between the ages of 20 and 50 that typically ate more in stressful situations. While the placebo group gained significant weight during the trial, the Relora group was able to maintain weight. Negative mood was related to weight gain in the control (placebo) group but not in the Relora group. According to the study, Relora appears to promote weight maintenance and decrease stress arousal as demonstrated by decreased evening cortisol and decreased systolic blood pressure. Relora is a proprietary formula of Magnolia officinalis and Phellodendron amurense.